TheraRadar
← Back
Data updated: Mar 29, 2026

STERISCIENCE

Infectious DiseaseDermatologyCardiovascular
Generics

STERISCIENCE is a generic drug manufacturer focused on Infectious Disease, Dermatology, Cardiovascular. Key products include FOCINVEZ.

1964
Since
9
Drugs
-
Trials
117
Approved (2yr)

Key Drugs

FOCINVEZ
fosaprepitant dimeglumine
NK1R 2 indications · 2023

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
METHYLENE BLUE 2026-02-02
Manufacturing (CMC)
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 43%
3 drugs
Dermatology 29%
2 drugs
Cardiovascular 14%
1 drugs
Metabolic 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
Bayer big-pharma
Cardiovascular, Dermatology, Metabolic